NVO — Novo Nordisk A/S Income Statement
0.000.00%
Last trade - 00:00
- $561.98bn
- $561.14bn
- DKK232.26bn
- 100
- 11
- 70
- 61
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 122,021 | 126,946 | 140,800 | 176,954 | 232,261 |
Cost of Revenue | |||||
Gross Profit | 102,462 | 106,014 | 117,142 | 148,506 | 196,496 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 69,538 | 72,820 | 82,156 | 102,145 | 129,687 |
Operating Profit | 52,483 | 54,126 | 58,644 | 74,809 | 102,574 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 48,553 | 53,130 | 59,080 | 69,062 | 104,674 |
Provision for Income Taxes | |||||
Net Income After Taxes | 38,951 | 42,138 | 47,757 | 55,525 | 83,683 |
Net Income Before Extraordinary Items | |||||
Net Income | 38,951 | 42,138 | 47,757 | 55,525 | 83,683 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 38,951 | 42,138 | 47,757 | 55,525 | 83,683 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 8.39 | 9.08 | 10.5 | 12.4 | 19 |
Dividends per Share |